...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Hypofractionated stereotactic radiosurgery for treatment of cerebral arteriovenous malformations: outcome analysis with use of the modified arteriovenous malformation scoring system
【24h】

Hypofractionated stereotactic radiosurgery for treatment of cerebral arteriovenous malformations: outcome analysis with use of the modified arteriovenous malformation scoring system

机译:超分割立体定向放射外科手术治疗脑动静脉畸形:使用改良的动静脉畸形评分系统进行结局分析

获取原文
获取原文并翻译 | 示例
           

摘要

Radiosurgery has long been an accepted modality for definitive treatment of cerebral arteriovenous malformations (AVM). Efforts to improve the therapeutic ratio for this indication include use of staged volume procedures and hypofractionation. This study reviews our experience with a cohort of patients treated with hypofractionated radiosurgery. Over a 3 year period, 38 patients harboring 39 cerebral AVM were treated with hypofractionated stereotactic radiotherapy. Seventeen of these patients presented due to hemorrhage, four were asymptomatic unruptured lesions and the remainder were symptomatic unruptured lesions. The median AVM volume was 11.43 cc and median modified Radiosurgery-Based Arteriovenous Malformation Score (mRBAS) was 2.02. The median follow-up was 7.32 years. Four patients harboring four AVM were lost to follow-up before a result could be ascertained leaving 35 AVM for analysis. Excellent outcomes (AVM obliteration without new deficits) occurred in 17 of 34 (50%) patients and in 18 of 35 (51%) AVM treated. AVM obliteration was seen in 26 of 35 (74%) lesions treated. Two patients died during the follow-up period (6%). A poor result (major deficit without obliteration) was seen in one patient. Of 19 patients harboring AVM with mRBAS >2.0, an excellent outcome was achieved in eight (42%). Hypofractionation for cerebral AVM can result in satisfactory obliteration rates, but with risk of significant complications commensurate with mRBAS. Further study of this technique will be needed to ascertain the degree of incremental improvement, if any, over other radiosurgery treatment methods. (c) 2015 Elsevier Ltd. All rights reserved.
机译:放射外科一直是确定性治疗脑动静脉畸形(AVM)的公认方式。改善该适应症的治疗率的努力包括使用分阶段的体积程序和超分割。这项研究回顾了我们对接受超分割放射外科手术治疗的患者的经验。在3年的时间里,对38例39例脑AVM患者进行了分级分割立体定向放射治疗。这些患者中有17例因出血而出现,其中4例是无症状的未破裂病变,其余为有症状的未破裂病变。平均AVM量为11.43 cc,基于放射外科手术的动静脉畸形评分(mRBAS)的中位数为2.02。中位随访时间为7。32年。在确定结果之前,有四名携带四个AVM的患者丢失了随访,剩下35个AVM用于分析。 34例患者中有17例(50%)发生了出色的预后(AVM消失而没有新的缺陷),AVM治疗的35例中有18例(51%)发生了极好的结果。在治疗的35个病变中,有26个(74%)可见AVM闭塞。随访期间有2例患者死亡(6%)。在一名患者中观察到差的结果(没有闭塞的严重缺损)。在19例mRBAS> 2.0的AVM患者中,有8例(42%)取得了优异的疗效。对脑AVM进行超分割可导致令人满意的闭塞率,但存在与mRBAS相称的重大并发症的风险。需要进一步研究该技术,以确定与其他放射外科治疗方法相比的增量改善程度(如果有)。 (c)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号